Clinical Trial Update: Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intramyometrial oxytocin during elective cesarean delivery has been withdrawn. The study was associated with postpartum hemorrhage an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Uterine Atony

Drugs mentioned

• intramyometrial oxytocin (oxytocin)

Snippet

Sponsor: University of Saskatchewan | Conditions: Postpartum Hemorrhage, Uterine Atony | Phase 4 | Status: WITHDRAWN